Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2

Sponsor Class

OTHER 2NIH 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 4Thoracic 2Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Neoplasm Metastasis 1

Interventions

Carboplatin 510Cisplatin 410Pemetrexed 400Radiotherapy 285Docetaxel 244Paclitaxel 227pembrolizumab 226Gemcitabine 198Drug Therapy 191Bevacizumab 190Erlotinib Hydrochloride 189Radiosurgery 177Nivolumab 168Etoposide 155durvalumab 154osimertinib 126atezolizumab 109Gefitinib 96Blood Specimen Collection 93Magnetic Resonance Spectroscopy 91Vinorelbine 90anlotinib 88Surgical Procedures, Operative 85Ipilimumab 62Immunotherapy 62Surveys and Questionnaires 60sintilimab 59Specimen Handling 59tislelizumab 58Irinotecan 57

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Biological Therapy × Thoracic × Clear all
NCT03176173 2025-11-05

Radical RADiotherapy and Immunotherapy for Metastatic CAncer of the Lung (RRADICAL)

Stanford University

Phase NA Completed
45 enrolled 13 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07111104 2025-08-08

ARIS

Hopitaux Prives de Metz, Groupe UNEOS

Completed
350 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡